Structure activity relationship, in vitro and in vivo profile of JN403, a nAChR a7 selective agonist

被引:0
|
作者
Nozulak, Joachim [1 ]
Hoyer, Daniel [1 ]
Chaperon, Frederique [1 ]
Lingenhoehl, Kurt [1 ]
Vassout, Annick [1 ]
Feuerbach, Dominik [1 ]
机构
[1] Novartis Inst BioMed Res, Basel, Switzerland
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 242卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
370-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [21] The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH
    Jensen, Anders A.
    Halberstadt, Adam L.
    Marcher-Rorsted, Emil
    Odland, Anna U.
    Chatha, Muhammad
    Speth, Nikolaj
    Liebscher, Gudrun
    Hansen, Martin
    Brauner-Osborne, Hans
    Palner, Mikael
    Andreasen, Jesper T.
    Kristensen, Jesper L.
    BIOCHEMICAL PHARMACOLOGY, 2020, 177
  • [22] In vivo and in vitro ADMET profiling and in vivo pharmacodynamic investigations of a selective α7 nicotinic acetylcholine receptor agonist with a spirocyclic Δ2-isoxazoline molecular skeleton
    Matera, Carlo
    Dondio, Giulio
    Braida, Daniela
    Ponzoni, Luisa
    De Amici, Marco
    Sala, Mariaelvina
    Dallanoce, Clelia
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 820 : 265 - 273
  • [23] Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity In Vitro and In Vivo
    Ohol, Yamini M.
    Sun, Michael T.
    Cutler, Gene
    Leger, Paul R.
    Hu, Dennis X.
    Biannic, Berenger
    Rana, Payal
    Cho, Cynthia
    Jacobson, Scott
    Wong, Steve T.
    Sanchez, Jerick
    Shah, Niket
    Pookot, Deepa
    Abraham, Betty
    Young, Kyle
    Suthram, Silpa
    Marshall, Lisa A.
    Bradford, Delia
    Kozon, Nathan
    Han, Xinping
    Okano, Akinori
    Maung, Jack
    Colas, Christophe
    Schwarz, Jacob
    Wustrow, David
    Brockstedt, Dirk G.
    Kassner, Paul D.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 1970 - 1980
  • [24] Discovery of potent and selective inhibitors of USP7 with anti-tumor activity in vitro and in vivo
    Ohol, Yamini M.
    Sun, Michael
    Leger, Paul
    Hu, Dennis
    Biannic, Berenger
    Rana, Payal
    Cho, Cynthia
    Jacobson, Scott
    Wong, Steve
    Sanchez, Jerick
    Han, Xinping
    Young, Kyle
    Okano, Akinori
    Maung, Jack
    Cutler, Gene
    Shah, Nick
    Adusumilli, Lavanya
    Kaveri, Deepika
    Talay, Oezcan
    Pookot, Deepa
    Abraham, Betty
    Bradford, Delia
    Kozon, Nathan
    Colas, Christophe
    Kim, Andrea
    Schwarz, Jacob
    Wustrow, David
    Brockstedt, Dirk
    Kassner, Paul
    CANCER RESEARCH, 2019, 79 (13)
  • [25] The in vivo -: Preclinical profile of TD-5108, a selective, high intrinsic activity 5-HT4 receptor agonist
    Beattie, David T.
    Armstrong, Scott R.
    Marquess, Daniel
    Shaw, Jeng-Peng
    Smith, Jacqueline A.
    Humphrey, Patrick P.
    GASTROENTEROLOGY, 2007, 132 (04) : A688 - A688
  • [26] Structure-activity relationship, in vitro and in vivo evaluation of novel dienyl sulphonyl fluorides as selective BuChE inhibitors for the treatment of Alzheimer's disease
    Wu, Chengyao
    Zhang, Guijuan
    Zhang, Zai-Wei
    Jiang, Xia
    Zhang, Ziwen
    Li, Huanhuan
    Qin, Hua-Li
    Tang, Wenjian
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 1860 - 1873
  • [27] The copper(II) complexes of new anthrahydrazone ligands: In vitro and in vivo antitumor activity and structure-activity relationship
    Liu, Rui-Xue
    Wang, Chen-Yu
    Wu, Ying-Shu
    Luo, Ru-Yi
    Jiang, Xiao-Hong
    Tang, Meng-Ting
    Liu, Yan-Cheng
    Chen, Zhen-Feng
    Liang, Hong
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2020, 212
  • [28] The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity
    Smith, J. A. M.
    Beattie, D. T.
    Marquess, D.
    Shaw, J. -P.
    Vickery, R. G.
    Humphrey, P. P. A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 378 (01) : 125 - 137
  • [29] The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity
    J. A. M. Smith
    D. T. Beattie
    D. Marquess
    J.-P. Shaw
    R. G. Vickery
    P. P. A. Humphrey
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 378 : 125 - 137
  • [30] Development of a potent and selective GPR7 agonist: A systematic structure-activity study of neuropeptide B
    Kanesaka, Maki
    Matsuda, Masao
    Hirano, Atsushi
    Tanaka, Kenichi
    Kanatani, Akio
    Tokita, Shigeru
    NEUROSCIENCE RESEARCH, 2007, 58 : S76 - S76